Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast.
about
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast CancerLeucoerythroblastosis and thrombocytopenia as clues to metastatic malignancy.Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study.Breast cancer prognostic classification in the molecular era: the role of histological grade.EZH2 expression in invasive lobular carcinoma of the breast.Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omicsInvasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes.Lobular neoplasia: frequency and association with other breast lesions.Platinum resistance in breast and ovarian cancer cell linesCase report and literature review: Metastatic lobular carcinoma of the breast an unusual presentation.Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system.Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study.Invasive lobular carcinoma predicts micrometastasis in breast cancer.Invasive pleomorphic lobular carcinoma of the breast: clinicopathologic characteristics and prognosis compared with invasive ductal carcinomaGenome and transcriptome delineation of two major oncogenic pathways governing invasive ductal breast cancer development.Transcriptome sequencing uncovers a three-long noncoding RNA signature in predicting breast cancer survival.Is There a Role for Oncotype Dx Testing in Invasive Lobular Carcinoma?The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches.Pleomorphic lobular carcinoma of the breast: molecular pathology and clinical impact.Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor.Histological types of breast cancer: how special are they?Pleomorphic lobular carcinoma: a distinctive clinical and molecular breast cancer type.A multivariate analysis on prognostic factors for lobular carcinoma of the breast.Genomic grade adds prognostic value in invasive lobular carcinoma.Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets.Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.[Histological grading of breast cancer].[Lobular neoplasms and invasive lobular breast cancer]Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticatorsPredicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers
P2860
Q26801108-6F0401A5-1D4C-4FF1-AD52-5C1E80031274Q33413084-1FD06DA0-8630-4FB9-881E-D68C9C91D85AQ33670486-CE21C32D-9BEE-4E79-8A20-0378D13D351FQ33761874-545446B7-D141-4521-8349-4CE4F6ED8FF4Q34173440-DA7BD60D-7A76-46F8-937E-5EF97C63BF44Q34462723-BF847B32-7751-4F29-8A49-EAF14A6A117EQ35025646-EAFB56E5-4ED8-4F5C-A34E-F9D8A7AA6324Q35086250-5FFE21B9-27FB-40E3-8295-FD0587D8DF6BQ35207074-AD7E05EC-ADDA-4A54-8139-D59DB770F40AQ35397906-EC814013-F699-4CD0-9E53-8368A79544DBQ35547452-CA175652-2987-4D67-920D-9C895B7A17F3Q35609695-DC455200-936C-428F-ACFE-B261F4957642Q35743495-841DD792-C2A0-452C-9BA8-0D6149CE2CA2Q36166242-60466E54-989F-4F5F-AF3A-EA743551C7DAQ36310199-24B582FB-7377-4801-8EB6-959A9FFEC4C5Q36546754-9451B5B3-8D8C-4BB1-9C29-BBF9F88FEFB9Q37034875-06C52846-61B2-4D6B-B56A-CB784D47DD61Q37199779-6EA95E9E-BCEB-4D50-8BAD-583F7A63CDCCQ37301836-A9C0AF2E-AA5A-45B9-925F-A7FCEF16A6CBQ37414366-AEB81188-DACC-4D4D-8BD8-73EC55381697Q37586533-7302CB98-0552-42D5-AE84-0069BEFA2185Q37746023-04771992-5B13-4BBD-A0DB-ED7EB296DE02Q42504631-BB97D6EB-64B6-48F3-BC75-0627AF29EAB5Q42852134-831C69D0-05EF-40A7-8D14-3513F1C01AC4Q44449196-49475312-AE0D-4954-A889-A82D062ABF01Q50246934-82059BAA-E17E-4FDA-81E1-AC571C8C522DQ52339904-A8E986C3-96EF-4F49-AB59-35A53BB98429Q53075565-93D52AA5-527B-464A-A918-207959A9D370Q57129131-D4DD9231-54E1-4EFC-883B-D9403E106CB8Q57568320-6F160C12-A9A2-4ADC-B444-D2359A83BEF0Q57816466-C789A714-7FD5-4E05-8EA4-50CC31E5EE02
P2860
Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Histologic grading is an indep ...... bular carcinoma of the breast.
@en
Histologic grading is an indep ...... bular carcinoma of the breast.
@nl
type
label
Histologic grading is an indep ...... bular carcinoma of the breast.
@en
Histologic grading is an indep ...... bular carcinoma of the breast.
@nl
prefLabel
Histologic grading is an indep ...... bular carcinoma of the breast.
@en
Histologic grading is an indep ...... bular carcinoma of the breast.
@nl
P2093
P2860
P50
P1476
Histologic grading is an indep ...... bular carcinoma of the breast.
@en
P2093
Andrew H S Lee
Maysa E El-Sayed
Sindhu Menon
P2860
P2888
P304
P356
10.1007/S10549-007-9768-4
P407
P577
2007-10-11T00:00:00Z